Scarica l'app Stockscreener
67.68
0.59%
0.40
Pre-mercato:
67.67
-0.01
-0.01%
Cg Oncology Inc Borsa (CGON) Ultime notizie
CGON Stock Up 60.8% in Six Months: Here's What You Need to Know - TradingView — Track All Markets
CG Oncology, Inc. Appoints New Chief Financial Officer Jim DeTore – Employment Agreement Details and Company Information - Minichart
Bull Bear: Will CG Oncology Inc outperform tech stocks2026 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn
CG Oncology Appoints Veteran Jim DeTore as Chief Financial Officer - TipRanks
CG Oncology appoints Jim DeTore as chief financial officer By Investing.com - Investing.com South Africa
CG Oncology appoints Jim DeTore as chief financial officer - Investing.com
CG Oncology appoints Jim DeTore as Chief Financial Officer - TradingView — Track All Markets
New CG Oncology (NASDAQ: CGON) CFO Jim DeTore gets $520k salary, equity - Stock Titan
CG Oncology (NASDAQ:CGON) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
SG Americas Securities Boosts Stake in CG Oncology - National Today
FY2027 EPS Estimates for CG Oncology Increased by Analyst - MarketBeat
Aug Big Picture: Is CG Oncology Inc stock a hidden gem2026 Macro Impact & AI Forecast Swing Trade Picks - baoquankhu1.vn
CG Oncology FY2029 EPS Forecast Increased by HC Wainwright - MarketBeat
Sivik Global Healthcare LLC Takes Position in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology stock hits all-time high at 69.41 USD By Investing.com - Investing.com Australia
Aug Sectors: What are the future prospects of CG Oncology Inc2026 Analyst Calls & Verified Technical Trade Signals - baoquankhu1.vn
CG Oncology stock hits all-time high at 69.41 USD - Investing.com
CG Oncology (NASDAQ:CGON) Hits New 52-Week High on Analyst Upgrade - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for CG Oncology (NASDAQ:CGON) Stock - MarketBeat
Oncolytic Virus Therapies Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | CG Oncology, Imugene, Amgen, Daiichi Sankyo, Genelux, Replimune, Binhui Biopharma - Barchart
H.C. Wainwright raises CG Oncology stock price target to $100 By Investing.com - Investing.com Canada
CGON Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Analyst Calls: What are the future prospects of CG Oncology IncDividend Hike & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
CEO Moves: Can CG Oncology Inc expand into new markets2026 Buyback Activity & Stepwise Swing Trade Plans - baoquankhu1.vn
CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Rating Downgrade) - Seeking Alpha
CG Oncology stock hits all-time high at 60.01 USD By Investing.com - Investing.com Australia
CG Oncology Stock Surges on Fresh Institutional Backing - TipRanks
CGON PE Ratio & Valuation, Is CGON Overvalued - Intellectia AI
Aug Action: What is the target price for CG Oncology Inc stock2026 EndofYear Setup & Consistent Return Strategy Ideas - baoquankhu1.vn
Trade Recap: Can CG Oncology Inc expand into new markets - baoquankhu1.vn
Portfolio Recap: Is CG Oncology Inc impacted by rising ratesMarket Weekly Review & Expert Approved Momentum Ideas - baoquankhu1.vn
CG Oncology, Inc. $CGON Stake Lifted by JPMorgan Chase & Co. - MarketBeat
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know - AOL.com
Analysts Are Bullish on These Healthcare Stocks: Gain Therapeutics (GANX), CG Oncology, Inc. (CGON) - The Globe and Mail
CG Oncology (NASDAQ:CGON) Downgraded by Wall Street Zen to Sell - MarketBeat
CG Oncology, Inc. (NASDAQ:CGON): Are Analysts Optimistic? - 富途牛牛
Vanguard realignment reports 0% ownership in CG Oncology (CGON) - Stock Titan
UBS raises CG Oncology stock price target to $90 on trial outlook - Investing.com India
UBS Adjusts Price Target on CG Oncology to $90 From $60, Maintains Buy Rating - MarketScreener
UBS raises CG Oncology stock price target to $90 on trial outlook By Investing.com - za.investing.com
Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ - openPR.com
Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - Barchart
CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Entrada Therapeutics Inc (TRDA), CG Oncology, Inc. (CGON) - The Globe and Mail
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - AOL.com
Kynam Capital Cuts CG Oncology Holding: Q4 2025 Sale Details & ImpactNews and Statistics - IndexBox
This Biotech Stock Surged 135% but Just Saw a $44 Million Sell-Off. What Does This Mean for Investors? - bitget.com
CGON Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Bank of America Securities Remains a Buy on CG Oncology, Inc. (CGON) - The Globe and Mail
CG Oncology (CGON) Expected to Announce Quarterly Earnings on Friday - MarketBeat
Quarterly Trades: Can CG Oncology Inc deliver consistent EPS growth2026 Key Highlights & Real-Time Price Movement Reports - baoquankhu1.vn
Why CG Oncology Stock Is Suddenly Losing Steam - TipRanks
CG Oncology, Inc. Hits New 52-Week High of $59.95 - Markets Mojo
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):